Skip to main content
Caplight Logo









AMO Pharma

AMO Pharma

Private
LeedsHealthcare & Life Scienceshttps://amo-pharma.com/

Last Round

Private Equity

Dec 6, 2022

Total Funding Raised

$25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AMO Pharma is a biopharmaceutical company that develops treatments for serious and debilitating rare genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalrare diseaseorphan drugclinical trialssmall-molecule therapypediatric medicineneurodevelopmental disordersdrug developmentneuromuscular disordersbiotechclinical-stage biotechdrug pipelinepharmacological intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMO Pharma Comparables

Compare AMO Pharma with similar companies based on industry and business-model similarity.

AMO Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuren Pharmaceuticals Limited
80%
Novartis
78%
Connecta Therapeutics
78%

AMO Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityDec 6, 2022
Private EquityMay 10, 2022
VC RoundJan 9, 2020
Private EquitySep 30, 2015

AMO Pharma Investors

Notable investors and investment history

AMO Pharma investors
InvestorRounds
Woodford Investment ManagementPrivate Equity
Woodford Patient Capital TrustPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 39% MoM to 5.2K.

  • Jun 1, 2025

    Monthly visitors increased 90% MoM.

AMO Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMO Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMO Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeeds
Employee Range6
Year Founded2014
Last FundingDec 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?